NIR Instrument for Singlet Oxygen Mapping during PDT

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$168,029.00
Award Year:
2009
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA139675-01
Award Id:
93537
Agency Tracking Number:
CA139675
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
RADIATION MONITORING DEVICES, INC. (Currently Radiation Monitoring Devices, Inc)
44 Hunt Street, WATERTOWN, MA, 02472
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
073804411
Principal Investigator:
MADHAVI SEETAMRAJU
() -
Business Contact:
GERALD ENTINE
() -
gentine@rmdinc.com
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): The focus of the proposal is in the area of dosimetry for photodynamic therapy (PDT), especially for breast cancer treatment. It is crucial that the optimal dosage of the three PDT components - photosensitizer, light fl uence, and oxygen - be involved for the successful outcome of the treatment. While under dosing can lead to recurrence of the cancer, over dosing can lead to undesirable healthy-tissue damage. A widely accepted method for accurate dosimetry is based on the fact that the quantity of cytotoxic nascent oxygen generated locally during PDT is directly correlated to the treatment outcome. Diffuse optical tomography (DOT) using near infrared light has been used successfully for functional imaging of breast tumors based on their endogenous and exogenous spectral contrast compared to healthy tissue. We will use this well- established DOT technique to perform real-time spatial mapping of nascent oxygen concentration based on the luminescence from the photosensitizer u nder light fluence. During Phase I, we will develop a detection methodology to demonstrate that the photosensitizer time dependent luminescence characteristics are directly correlated to PDT outcome. Based on the results of Phase I, we will develop a proto type of the spatial nascent oxygen imaging module during Phase II, which will have parallel acquisition across a cooled multi-detector array for high resolution and high throughput imaging. The low-cost, compact PDT dosimetric imager module will be designe d to be compatible with existing DOT systems to extend their applications for monitoring during PDT for breast and other cancer treatments. PUBLIC HEALTH RELEVANCE: Diffuse luminescence imaging can be used to obtain quantitative spatial maps of nas cent oxygen concentration based on time domain characteristics of the drugs used in photodynamic therapy (PDT). PDT following breast lumpectomy to prevent local recurrence of cancer is the primary target application, with the goal of improving treatment ou tcome and minimizing side effects. Other applications could include monitoring for dose evaluation during PDT treatments in brain cancers, head and neck cancers, and other non-cancerous conditions.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government